While clinical trials are considered the fastest way to determine if a proposed intervention is safe and effective, they include both potential benefits and risks. A trial participant has the chance to receive a potentially promising treatment that is not available to the general public and to receive care at the nation’s top academic medical centers and research institutes. Broad and diverse participation in a clinical trial also ensures that the treatment, drug or device will be effective for everyone, not just a segment of the population.
However, those participating in clinical trials face the chance that their disease or condition will not improve with the experimental treatment, and they could experience adverse side effects, among other possible drawbacks.
What is most important for patients is knowledge about and access to clinical trials, so they have the opportunity to participate if they choose and can make informed decisions about their health.
一道本不卡免费高清The details of a clinical trial, including all tests and procedures used in the trial, are outlined in a research plan, usually called a protocol. Before a clinical trial can begin, the protocol must be approved by .
一道本不卡免费高清After a clinical trial is approved by the IRB, a UCSF team of researchers, clinicians and other patient care specialists oversees the trial and all interactions with the research volunteers. This team follows strict rules set forth by the U.S. Food and Drug Administration and other government agencies regarding clinical trial processes. The rules ensure that people who participate in clinical trials are treated as safely as possible.
A clinical trial is paid for by the organization that sponsors the research, which may be a drug or medical device company, as well as by private foundations, gifts to UCSF, faculty members on the trial team or the departments of the UCSF faculty members.